Expert consensus of China on radiation therapy for gliomas in 2017
10.3760/cma.j.issn.1004-4221.2018.02.001
- VernacularTitle:胶质瘤放疗中国专家共识(2017)
- Author:
China Society for Radiation Oncology
- Keywords:
Glioma/radiotherapy;
Consensus
- From:
Chinese Journal of Radiation Oncology
2018;27(2):123-131
- CountryChina
- Language:Chinese
-
Abstract:
Gliomas is a global cell-originated tumor that is the most common primary intracranial tumor.World Health Organization (WHO) classification of glioma is WHO Ⅰ-Ⅳ,and WHO Ⅰ-Ⅱ are the lower-grade gliomas(LGG),WHO Ⅲ-Ⅳ are the higher-grade gliomas(HGG).With the development of modern radiotherapy and radiobiology,radiation therapy become an integral role in treating gliomas.Different grade of the gliomas will have different characteristics and treatment strategy.China expert diagnosis and treatment guildline of central nervous system glioma has been published in 2016.However,there was no relevant consensus specialized on glioma radiotherapy in China untill now.Therefore,after discussion and communication according to evidencebased medicine,a consensus was made among China Society for Radiation Oncology (CSTRO) composed of Chinese glioma experts.The consensus includes radiation therapy for HGG,LGG,diffuse intrinsic pontine glioma,ependymom,recurrent spinal cord glioblastoma,elderly patients,pediatric gliomas and pseudoprogression.The consensus will provide in-depth analysis and summarize the concernedquestion of radiation therapy in clinical work.Meanwhile,this consensus would strive to further standardize the application of radiation therapy in glioma treatment to provide evidence-based guidance.
